Strides Shasun Gets USFDA Go-Ahead For Anti-Allergy Drug Business Business / Business 7 years ago 382 Views comments Citing IMS sales data, Strides Shasun said the US market for the approved product is approximately $17 million. Read more
Business Money Guru: Know how to plan a successful retirement | जानिए कैसे करे एसेट एलोकेशन Business / Business - 7 years ago
Business NSE spokesperson: Markets trading resumes in F&O shares after technical issues Business / Business - 7 years ago
Business Commodity Live: Gold prices expected to fall by Rs 1000/10 gm Business / Business - 7 years ago
Business Quintiles IMS: 50-70% of chemists in key cities not ready for July 1 GST roll out Business / Business - 7 years ago
Business Superfast Futures: Reliance Industries to remain in focus today Business / Business - 7 years ago
Comments